A detailed history of Cwm, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Cwm, LLC holds 14 shares of XENE stock, worth $537. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 7 100.0%
Holding current value
$537
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$36.12 - $43.96 $252 - $307
7 Added 100.0%
14 $1,000
Q2 2024

Jul 09, 2024

BUY
$36.25 - $43.75 $253 - $306
7 New
7 $0

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.